Calavo Growers, Inc. Announces $25 Million Stock Repurchase Program

Stock Information for G1 Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About G1 Therapeutics Inc.

Calavo Growers Announces Leadership Transition
Calavo Growers, Inc. to Provide General Business Update at 2025 Annual Meeting of Shareholders
Calavo Growers, Inc. Announces First Quarter 2025 Financial Results
Calavo Growers to Report First Quarter 2025 Financial Results
Calavo Growers, Inc. Announces Third Quarter 2024 Financial Results, Dividend Increase
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Calavo Growers to Report Third Quarter Financial Results
Calavo Growers Completes Sale of Fresh Cut Business

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.